2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycythemia Vera
11
Brain Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
9
Leukemia, Myeloid, Chronic-Phase
9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
9
Leukemia
9
Glioblastoma
9
Leukemia, Myeloid, Acute
8
Meningioma
7
Head and Neck Neoplasms
7
Gliosarcoma
6
Myelodysplastic Syndromes
4
Glioma
4
Central Nervous System Neoplasms
4
Neoplasms
3
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
3
Laryngeal Neoplasms
3
Esophageal Neoplasms
3
Treatment-Refractory Solid Tumors
2
Thrombocythemia, Essential
2
Stomach Neoplasms
2
Salivary Gland Neoplasms
2
Primary Myelofibrosis
2
Pharyngeal Neoplasms
2
Paranasal Sinus Neoplasms
2
Oropharyngeal Neoplasms
2
Myelodysplastic-Myeloproliferative Diseases
2
Hypopharyngeal Neoplasms
2
Interventions
Lenalidomide
2
Dexamethasone
2
Bortezomib
2
ruxolitinib
1
posaconazole
1
darinaparsin
1
carfilzomib
1
belinostat
1
Stem Cell Transplantation
1
SCIO-469
1
Low-Level Light Therapy
1
Hydroxyurea
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bone Marrow Neoplasms
×
Hydroxyurea
×
Clear all
NCT04217356
2026-01-26
ALLO-BAT
University Health Network, Toronto
Active not recruiting
90 enrolled